Child psychopharmacology: How school psychologists can contribute to effective outcomes

School Psychology Quarterly

Volumn 20, Issue 2, 2005, Pages 206-221

  DuPaul, George J ^a   Carlson, John S ^b,c  

^a LEHIGH UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Lehigh University ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22144493319     PISSN: 10453830     EISSN: None     Source Type: Journal    
DOI: 10.1521/scpq.20.2.206.66511     Document Type: Article

References (45)

1. American Psychological Association (2002). Ethical principles of psychologists and code of ethics. American Psychologist, 57, 1060-1073.
2. Brown, R. T., & Sammons, M. T. (2002). Pediatrie psychopharmacology: A review of new developments and recent research. Professional Psychology: Research and Practice, 33, 135-147.
3. Carlson, J. S. (2001). Empirical support for training in school psychopharmacology. Trainer's Forum: Periodical of the Trainer's of School Psychologists, 20, 6-11.
4. Carlson, J. S., & Demaray, M. K. (2001). A survey of knowledge and training in school psychopharamacology. Poster presented at the annual National Association of School Psychologists Convention, Washington, DC.
5. Connor, D., & Barkley, R. A. (in press). Stimulants. In R. A. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed.). New York: Guilford.
6. dosReis, S., Zito, J. M., Safer, D. J., Soeken, K. L., Mitchell, J. W., & Ellwood, L. C. (2003). Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics, 24, 155-162.
7. Gadow, K.D. (1993). A school-based medication evaluation program. In J. L. Matson (Ed.), Handbook of hyperactivity in children (pp. 186-219). Needham Heights, MA: Allyn & Bacon.
8. Gureasko-Moore, D. P., DuPaul, G. J., & Power, T. J. (in press). Stimulant treatment for attentiondeficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review.
9. Handen, B. L., Breaux, A. M., Jonosky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 455-461.
10. HaileMariam, A., Bradley-Johnson, S., & Johnson, C. M. (2002). Pediatricians' preferences for ADHD information from schools. School Psychology Review, 31, 94-105.
11. Herranz, J. L., Armijo, J. A., & Arteaga, R. (1988). Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia, 29, 794-804.
12. Hoza, B., Pelham, W. E., Sams, S. E., & Carlson, C. (1992). An examination of the "dosage" effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children. Behavior Modification, 16, 164-192.
13. Hyman, I. A., Wojtowicz, A., Lee, K. D., Haffher, M. E., Fiorello, C. A., Storlazzi, J. J., & Rosenfeld, J. (1998). School-based methylphenidate placebo protocols: Methodological and practical issues. Journal of Learning Disabilities, 31, 581-594.
14. Jacobsen, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
15. Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557-565.
16. Kainz, K. (2002). Barriers and enhancements to physician-psychologist collaboration. Professional Psychology: Research and Practice, 33, 169-175.
17. Kiresuk, T. J., Smith, A., Cardillo, J. E. (1994). Goal attainment scaling: Applications, theory, and measurement. Hillsdale, NJ: Lawrence Erlbaum Associates.
18. Kratochwill, T. R., Elliott, S. N., Loitz, P. A., Sladeczek, I., & Carlson, J. S. (2003). Conjoint consultation using self-administered manual and videotape parent-teacher training: Effects on children's behavioral difficulties. School Psychology Quarterly, 18, 269-302.
19. Kratochwill T. R., & Stoiber K. C: (2002) Evidence-based interventions in school psychology: Conceptual foundations of the Procedural and Coding Manual of Division 16 and the Society for the Study of School Psychology Task Force. School Psychology Quarterly 17, 341-389.
20. Kubiszyn, T. (1994). Pediatric psychopharmacology and prescription privileges: Implications and opportunities for school psychology. School Psychology Quarterly, 9, 26-40.
21. Mattison, R. (1999). Use of psychotropic medications in special education students with serious emotional disturbance. Journal of Child and Adolescent Psychopharmacology, 9, 143-155.
22. Medco Health Solutions (2004). Drug Trend Report. Author.
23. MTA Cooperative Group (1999). A 14-month randomized clinical trial of treatment strategies for ADHD. Archives of General Psychiatry, 56, 1073-1086.
24. National Association of School Psychologists (2000). National Association of School Psychologists: Professional Conduct Manual. Bethesda, MD: Author.
25. National Conference of State Legislators (2004, August 12). Psychotropic medication at school. Retrieved September 30, 2004 from http://www.ncsl.org/ programs/health/ritalin.htm.
26. National Institute of Mental Health (1985). Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin, 21, 839-843.
27. Nealis, L. (2004). The child medication safety act. Communique, 33, 14.
28. Olfson, M., Marcus, S. C., & Weissman, M. M. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521.
29. Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., et al. (2000). Behavioral versus behavioral and pharmacological treatment in ADHD attending a summer treatment program. Journal of Abnormal Child Psychology, 28, 507-525.
30. Phelps, L., Brown, R. T., & Power, T. (2002). Pediatric Psychopharmacology: Combining medical and psychological interventions. Washington DC: American Psychological Association.
31. Pliszka, S. R., Greenhill, L. L., Crismon, M. L., Sedillo, A., Carlson, C., Conners, C. K. et al. (2000). The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder, Part I: Attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 908-919.
32. Poling, A., Gadow, K. D., & Cleary, J. (1991). Drug therapy for behavior disorders: An introduction. New York: Pergamon.
33. Power, T. J., DuPaul, G. J., Shapiro, E. S., & Kazak, A. E. (2003). Promoting children's health: Integrating school, family, and community. New York: Guilford.
34. Power, T. J., Shapiro, E. S., & DuPaul, G. J. (2003). Preparing psychologists to link systems of care in managing and preventing children's health problems. Journal of Pediatric Psychology, 28, 147-156.
35. Riddle, M. A., Kastelic, E. A., & Frosch, E. (2001). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry and Allied Disciplines, 42, 73-90.
36. Sheridan, S. M., Eagle, J. W., Cowan, R. J., & Mickelson, W. (2001). The effects of conjoint behavioral consultation results of a 4-year investigation. Journal of School Psychology, 39, 361-385.
37. Sheridan, S. M., Kratochwill, T. R., & Bergan, J. R. (1996). Conjoint behavioral consultation: A procedureal manual. New York: Plenum.
38. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
39. Stoner, G., Carey, S. P., Ikeda, M. J., & Shinn, M. R. (1994). The utility of curriculum-based measurement for evaluating the effects of methylphenidate on academic performance. Journal of Applied Behavior Analysis, 27, 101-114.
40. Trimble, M. R. (1990). Antiepileptic drugs, cognitive function, and behaviour in children: Evidence from recent studies. Epilepsia, 31 (Suppl.4), 30-34.
41. United States Department of Health and Human Services (1999). Mental health: A report of the Surgeon General. Washington, DC: U.S. Government Printing Office.
42. Whitaker, A., & Rao, U. (1992). Neuroleptics in pediatric psychiatry. In D. Shaffer (Ed.), The psychiatric clinics of North America (Vol. 15, pp. 243-276). Philadelphia: Saunders.
43. Wilens, T., Biederman, J., Kwon, A., Chase, R., Greenberg, L., Mick, E., et al. (2003). A systematic chart review of the nature of psychiatric adverse effects in children and adolescents treated with selective serotonin reuptake inhibitors. Journal of Adolescent Psychopharmacology, 13, 143-152.
44. Zito, J. M., Derivan, A. T., & Greenhill, L. L. (2004). Making research data available: An ethical imperactive demonstrated by the SSRI debacle. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 512-514.
45. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Socken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17-25.